PERSTA(03395.HK)控股股東股權結構現變動
PERSTA(03395.HK)公布,接獲公司控股股東Aspen Investment的通知,告知吉林弘原與伯樂已於9月3日訂立一份協議,據此,吉林弘原將在不遲於該協議日期後的第60天購買而伯樂將出售1648557 Alberta(164 Co)持有的所有Aspen股份。
於完成向吉林弘原出售164Co持有的Aspen股份後,吉林弘原將成為Aspen約80.78%已發行股份總數的擁有人,而Aspen餘下19.22%的已發行股份總數將繼續由麗源持有。因此,景元將繼續維持對Aspen的股權控制,及Aspen將繼續為公司的控股股東。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.